Under the terms of the agreement, Lydall Solutech, a Lydall, Inc. (NYSE: LDL) company, will provide Shrink with certain quantities of its Solupor® membrane for the purpose of conducting a one-year research and development project. The goal of the project is to develop a robust, ultra-rapid diagnostic platform that increases the sensitivity of fluorescent-based assays by integrating Solupor technology with Shrink’s rapid prototyping system, ShrinkChip Manufacturing System™ and NanoPetal™ technology. Under the terms of the agreement, any ownership of new intellectual property will be based on inventorship.
Mark L. Baum, CEO of Shrink Nanotechnologies, stated, “This new relationship with Lydall Solutech is part of our effort to turn our NanoShrink materials into viable systems used in critical point-of-care and point-of-operations products. The market for these types of sensors is in the billions of US Dollars in annual sales, and they are used in a wide range of commercial applications such as food safety, personalized drug therapies and disease screening, to name a few. By producing more of the overall system solution, with the integration of the Lydall Solutech Solupor® material, we seek to increase the flexibility and scope of these important diagnostic devices and in turn open the door to future strategic partnerships with leading research laboratories in industry and academia.”
About Lydall, Inc.
Lydall, Inc. is a New York Stock Exchange listed company (LDL), headquartered in Manchester, Connecticut. With operations in the U.S., France, the Netherlands and Germany and sales offices in the U.S., Europe, and Asia, focuses on manufacturing specialty engineered products for the thermal/acoustical and filtration/separation markets. For more information, visit http://www.lydall.com.
Lydall® is a registered trademark of Lydall, Inc. in the U.S. and other countries. All product names are trademarks of Lydall, Inc. or Lydall Solutech BV.
